By melissa | Published: July 27, 2010
The objectives of this study are to explore the efficacy, safety, and tolerability of APC in acne patients with mild to moderate facial acne vulgaris. In this exploratory trial, 48 patients were treated with oral APC thrice a day for 3 months followed by a 4-week treatment-free period. At the end of treatment (Week 12), there was a statistically significant improvement in the global acne count (p < 0.05), which began after 8 weeks (p < 0.05)
Posted in Acne News | Also tagged a-day-for, acne-vulgaris-, and-papules, explore-the, global, moderate-facial, months-followed, patients, patients-were, thrice-daily, treated-with, two-patients, which-began
An observational study of methionine-bound zinc with antioxidants for mild to moderate acne vulgaris